| 中文名 | 7-氯-3,4-二氢-1H-苯并[E][1,4]二氮杂卓-2,5-二酮 |
|---|---|
| 英文名 | 7-Chloro-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione |
| 中文别名 | 7-氯-3,4-二氢-1H-苯并[e][1,4]二氮杂卓-2,5-二酮 |
| 英文别名 |
7-chloro-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
7-CHLORO-3H-1,4-BENZODIAZEPIN-2,5(1H,4H)-DIONE |
| 密度 | 1.394g/cm3 |
|---|---|
| 沸点 | 572ºC at 760mmHg |
| 分子式 | C9H7ClN2O2 |
| 分子量 | 210.61700 |
| 闪点 | 299.7ºC |
| 精确质量 | 210.02000 |
| PSA | 58.20000 |
| LogP | 1.48870 |
| 折射率 | 1.58 |
| 储存条件 | 2-8°C,密封,干燥 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):0.8 2.氢键供体数量:2 3.氢键受体数量:2 4.可旋转化学键数量:0 5.互变异构体数量:24 6.拓扑分子极性表面积:58.2 7.重原子数量:14 8.表面电荷:0 9.复杂度:270 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 海关编码 | 2933990090 |
|---|
|
~73%
5177-39-9 |
| 文献:State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
|
~%
5177-39-9 |
| 文献:Gates, Marshall Journal of Organic Chemistry, 1980 , vol. 45, # 9 p. 1675 - 1681 |
|
~55%
5177-39-9 |
| 文献:Gupta, Renu; Sirohi, Reenu; Shastri, Sudha; Kishore Heterocyclic Communications, 2003 , vol. 9, # 4 p. 363 - 366 |
|
~%
5177-39-9 |
| 文献:Sabb, Annmarie L.; Vogel, Robert L.; Welmaker, Gregory S.; Sabalski, Joan E.; Coupet, Joseph; Dunlop, John; Rosenzweig-Lipson, Sharon; Harrison, Boyd Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 10 p. 2603 - 2607 |
| 上游产品 5 | |
|---|---|
| 下游产品 2 | |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |